Last reviewed · How we verify
NCT04962711
Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)
NA trial testing Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP) in Heart Failure in 685 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Baker Heart and Diabetes Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 685 |
| Start date | 30 March 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP)
- Usual care
Conditions studied
- Heart Failure — all drugs for Heart Failure →
Sponsor
Baker Heart and Diabetes Institute
Who can join
Adults 40 to 85, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective study in which a process of identifying and reducing heart failure (HF) risk will be applied to cancer survivors \>55 years old with chemotherapy \>5 years ago. The overall goal of this study to identify the feasibility and value of risk-guided cardiac rehabilitation (exercise, risk factor modification, and behavioural support) as a component of survivorship care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments: Baseline results of the REDEEM trial.
Wong J, Smith J, Soh CH, Howden E, et al · · 2026 · cited 1× · PMID 40967296 · DOI 10.1016/j.ahj.2025.09.009
Verify or expand the search:
- PubMed search for NCT04962711
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Baker Heart and Diabetes Institute trials
Trials by the same sponsor.
- NCT06925529 — Exercise to Improve Neurovascular Function in Breast Cancer Survivors · NA · not yet recruiting
- NCT06742905 — Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER) · NA · not yet recruiting
- NCT05558605 — Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment · NA · recruiting
- NCT04983823 — Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE) · NA · recruiting
- NCT04966117 — Risk-guided Disease Management in Coronary Artery Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04962711 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baker Heart and Diabetes Institute
- Last refreshed: 31 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962711.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing